| Literature DB >> 29403648 |
Fortress Yayra Aku1,2, Patricia Akweongo1, Kofi Nyarko1, Samuel Sackey1, Fredrick Wurapa1, Edwin Andrew Afari1, Donne Kofi Ameme1, Ernest Kenu1.
Abstract
BACKGROUND: Globally, 4 million neonates die annually, with one-third of such deaths occurring as a result of infections. In 2011, there were 7.2million deaths in children below 5 years globally, and a proportion of 40% of these deaths occurred in neonates. Sepsis was reported to account for one-third of these deaths. Presently, multidrug antibiotic resistance is rapidly increasing in Neonatal Intensive Care Units (NICUs), particularly in developing countries and poses a threat to public health. The change in these organisms has been reported to vary across regions, between health facilities and even within the same facility. Continuous surveillance is required to inform antibiotic choice for neonatal sepsis management. We identified the common causative organisms of neonatal sepsis and their antibiotic susceptibility pattern in the Ho municipality.Entities:
Keywords: Antibiotics; Neonatal sepsis; Newborn
Year: 2018 PMID: 29403648 PMCID: PMC5778684 DOI: 10.1186/s40748-017-0071-z
Source DB: PubMed Journal: Matern Health Neonatol Perinatol ISSN: 2054-958X
Characteristics of neonates with suspected sepsis on admission at NICU, Ho municipality, 2016
| Variable | Count (N) | Percent (%) |
|---|---|---|
| Sex | ||
| Male | 91 | 60.7 |
| Female | 59 | 39.3 |
| Birth weight | ||
| < 2500 g | 35 | 24.5 |
| ≥ 2500 g | 108 | 75.5 |
| Place of birth | ||
| Within study facilities | 109 | 72.7 |
| Outside study facilities | 41 | 27.3 |
| Sepsis category | ||
| Early onset sepsis | 81 | 54 |
| Late onset sepsis | 69 | 46 |
| Gestational age | ||
| ≤ 36 | 41 | 27.3 |
| 37–40 | 94 | 62.7 |
| ≥ 41 | 15 | 10 |
| Length of hospital stay | ||
| ≤ 7 days | 77 | 51.3 |
| ≥ 8 days | 73 | 48.7 |
| Delivery mode | ||
| SVD | 63 | 42 |
| C/S | 87 | 58 |
| Position of lines | ||
| Central placed | 105 | 70 |
| Peripheral IV catheter | 45 | 30 |
SVD spontaneous vaginal delivery, C/S caesarean section
Distribution of maternal socio-demographic characteristics
| Variable | Count (N) 150 | Percent (%) |
|---|---|---|
| Age | ||
| ≤ 20 | 20 | 13.3 |
| 21–30 | 71 | 47.3 |
| ≥ 31 | 59 | 39.3 |
| Marital status | ||
| Married | 108 | 72 |
| Single | 41 | 27.3 |
| Divorced | 1 | 0.7 |
| Residence | ||
| Within Ho Municipality | 52 | 34.7 |
| Outside Ho Municipality | 98 | 65.3 |
| Ethnicity | ||
| Ewes | 136 | 90.7 |
| Akan | 9 | 6 |
| Northern descent | 5 | 3.3 |
| Religion | ||
| Christianity | 142 | 94.7 |
| Islam | 6 | 4 |
| Traditional African Belief | 2 | 1.3 |
| Educational level | ||
| No formal education | 12 | 8 |
| Primary | 18 | 12 |
| JSS | 59 | 39.3 |
| SSS | 35 | 23.3 |
| Tertiary | 26 | 17.3 |
| Employment | ||
| Employed | 122 | 81.3 |
| Unemployed | 28 | 18.7 |
Distribution of isolates of blood culture of neonates with sepsis
| Isolate | Early Onset Sepsis | Late Onset Sepsis | |||
|---|---|---|---|---|---|
| Count | Percentage (%) | Count | Percentage (%) | Total Count (N) | |
| Gram Positive organism | |||||
| | 9 | 69.2 | 5 | 38.5 | 14 |
| | 1 | 7.7 | 3 | 23.1 | 4 |
| Gram Negative organism | |||||
| | 1 | 7.7 | 0 | 0 | 1 |
| | 2 | 15.4 | 2 | 15.4 | 4 |
| | 0 | 0 | 2 | 15.4 | 2 |
| | 0 | 0 | 1 | 7.7 | 1 |
| Total | 13 | 13 | 26 | ||
Percentage resistance of gram positive organisms isolated from blood culture
| Isolate | Count (N) | AMP | GEN | CRX | COT | PEN | FLU |
|---|---|---|---|---|---|---|---|
|
| 14 | 100 | 57 | 64 | 100 | 100 | 100 |
|
| 4 | 100 | 50 | 75 | 50 | 100 | – |
AMP ampicillin, GEN gentamicin, CRX cefuroxime, COT cotrimoxazole, PEN penicillin, FLU flucloxacillin
Percentage resistance of gram negative organisms isolated from blood culture
| Isolate | Count (N) | AMP | GEN | CRX | COT | CTR | CTX |
|---|---|---|---|---|---|---|---|
| Pseudomonas aeruginosa | 4 | 100 | 25 | 75 | 75 | 25 | 50 |
| Escherichia | 1 | 100 | 0 | 0 | 100 | 0 | 0 |
| Enterobacter species | 2 | 100 | 50 | 50 | 50 | 50 | 100 |
| Proteus mirabilis | 1 | 100 | 100 | 100 | 100 | 0 | 0 |
I Intermediate susceptibility, AMP ampicillin, GEN gentamicin, CRX cefuroxime, COT cotrimoxazole, CTR ceftriaxone, CTX cefotaxime, I intermediate